179 related articles for article (PubMed ID: 29027415)
1. [Application of quality by design in granulation process for Ginkgo leaf tablet (Ⅲ)： process control strategy based on design space].
Cui XL; Xu B; Sun F; Dai SY; Shi XY; Qiao YJ
Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(6):1048-1054. PubMed ID: 29027415
[TBL] [Abstract][Full Text] [Related]
2. [Application of quality by design in granulation process for ginkgo leaf tablet (Ⅱ)： identification of critical quality attributes].
Xu B; Cui XL; Yang C; Wang X; Shi XY; Qiao YJ
Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(6):1043-1047. PubMed ID: 29027414
[TBL] [Abstract][Full Text] [Related]
3. [Application of quality by design in granulation process for ginkgo leaf tablet (Ⅳ)： influence and control of raw materials' quality variation].
Cui XL; Xu B; Liu JW; Shi GL; Shi XY; Qiao YJ
Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(6):1055-1061. PubMed ID: 29027416
[TBL] [Abstract][Full Text] [Related]
4. [Quality by design based high shear wet granulation process development for the microcrystalline cellulose].
Luo G; Xu B; Sun F; Cui XL; Shi XY; Qiao YJ
Yao Xue Xue Bao; 2015 Mar; 50(3):355-9. PubMed ID: 26118117
[TBL] [Abstract][Full Text] [Related]
5. [Application of quality by design in granulation process for ginkgo leaf tablet (Ⅰ)： comprehensive characterization of granule properties].
Cui XL; Xu B; Zhang Y; Zhang N; Shi XY; Qiao YJ
Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(6):1037-1042. PubMed ID: 29027413
[TBL] [Abstract][Full Text] [Related]
6. [Optimize dropping process of Ginkgo biloba dropping pills by using design space approach].
Shen JC; Wang QQ; Chen A; Pan FL; Gong XC; Qu HB
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2479-2483. PubMed ID: 28840687
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Study of Intermediate and Critical Quality Attributes for Process Control of High-Shear Wet Granulation Using Multivariate Analysis and The Quality by Design Approach.
Han JK; Shin BS; Choi DH
Pharmaceutics; 2019 Jun; 11(6):. PubMed ID: 31159393
[TBL] [Abstract][Full Text] [Related]
8. HIGH-SHEAR GRANULATION PROCESS: INFLUENCE OF PROCESSING PARAMETERS ON CRITICAL QUALITY ATTRIBUTES OF ACETAMINOPHEN GRANULES AND TABLETS USING DESIGN OF EXPERIMENT APPROACH.
Fayed MH; Abdel-Rahman SI; Alanazi FK; Ahmed MO; Tawfeek HM; Al-Shedfat RI
Acta Pol Pharm; 2017 Jan; 74(1):235-248. PubMed ID: 29474779
[TBL] [Abstract][Full Text] [Related]
9. New gentle-wing high-shear granulator: impact of processing variables on granules and tablets characteristics of high-drug loading formulation using design of experiment approach.
Fayed MH; Abdel-Rahman SI; Alanazi FK; Ahmed MO; Tawfeek HM; Al-Shdefat RI
Drug Dev Ind Pharm; 2017 Oct; 43(10):1584-1600. PubMed ID: 28480773
[TBL] [Abstract][Full Text] [Related]
10. The combined effect of wet granulation process parameters and dried granule moisture content on tablet quality attributes.
Gabbott IP; Al Husban F; Reynolds GK
Eur J Pharm Biopharm; 2016 Sep; 106():70-8. PubMed ID: 27016211
[TBL] [Abstract][Full Text] [Related]
11. A novel approach to support formulation design on twin screw wet granulation technology: Understanding the impact of overarching excipient properties on drug product quality attributes.
Willecke N; Szepes A; Wunderlich M; Remon JP; Vervaet C; De Beer T
Int J Pharm; 2018 Jul; 545(1-2):128-143. PubMed ID: 29684559
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic basis for the effects of process parameters on quality attributes in high shear wet granulation.
Badawy SI; Narang AS; LaMarche K; Subramanian G; Varia SA
Int J Pharm; 2012 Dec; 439(1-2):324-33. PubMed ID: 22981985
[TBL] [Abstract][Full Text] [Related]
13. The evolution of granule fracture strength as a function of impeller tip speed and granule size for a novel reverse-phase wet granulation process.
Wade JB; Martin GP; Long DF
Int J Pharm; 2015 Jul; 488(1-2):95-101. PubMed ID: 25888799
[TBL] [Abstract][Full Text] [Related]
14. Dextrose monohydrate as a non-animal sourced alternative diluent in high shear wet granulation tablet formulations.
Mitra B; Wolfe C; Wu SJ
Drug Dev Ind Pharm; 2018 May; 44(5):817-828. PubMed ID: 29300107
[TBL] [Abstract][Full Text] [Related]
15. Improved Understanding of the High Shear Wet Granulation Process under the Paradigm of Quality by Design Using
Zhang Y; Cheng BC; Zhou W; Xu B; Gao X; Qiao Y; Luo G
Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31600941
[TBL] [Abstract][Full Text] [Related]
16. High-shear granulation of high-molecular weight hypromellose: effects of scale-up and process parameters on flow and compaction properties.
Grdešič P; Sovány T; German Ilić I
Drug Dev Ind Pharm; 2018 Nov; 44(11):1770-1782. PubMed ID: 29968491
[TBL] [Abstract][Full Text] [Related]
17. Analysis of wet granulation process with Plackett-Burman design--case study.
Woyna-Orlewicz K; Jachowicz R
Acta Pol Pharm; 2011; 68(5):725-33. PubMed ID: 21928718
[TBL] [Abstract][Full Text] [Related]
18. Managing API raw material variability during continuous twin-screw wet granulation.
Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Vervaet C; De Beer T
Int J Pharm; 2019 Apr; 561():265-273. PubMed ID: 30851387
[TBL] [Abstract][Full Text] [Related]
19. Effects of granulation process variables on the physical properties of dosage forms by combination of experimental design and principal component analysis.
Thapa P; Choi DH; Kim MS; Jeong SH
Asian J Pharm Sci; 2019 May; 14(3):287-304. PubMed ID: 32104459
[TBL] [Abstract][Full Text] [Related]
20. The Influence of Wet Granulation Parameters on the Compaction Behavior and Tablet Strength of a Hydralazine Powder Mixture.
Macho O; Gabrišová Ľ; Guštafík A; Jezso K; Juriga M; Kabát J; Blaško J
Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
